Abstract. We determined the full-length genome sequence of Japanese encephalitis virus (JEV) K94P05 isolated in Korea. Sequence analysis showed that the 10,963-nucleotide-long RNA genome of K94P05 was 13 or 14 nucleotides shorter than the genome of other JEV isolates because of a deletion in the 3Ј noncoding region of K94P05. Compared with sequences of other JEV isolates, the full-length nucleotide sequence showed 89.0-89.6% homology, and the deduced amino acid sequence showed between 96.4-97.3% homology. A region of ϳ 60 nucleotides immediately downstream of the open reading frame stop codon of K94P05 showed high sequence variability as compared with other JEV isolates. K94P05 formed a distinct group within a phylogenetic tree established with the full-length genome sequences. Cross-neutralization studies showed that polyclonal antibodies to Korean isolates were 3 times better at neutralizing the Korean isolates than antibodies to Nakayama-NIH. These findings suggest that Korean JEV K94P05 is genetically and antigenically distinct from other Asian JEV isolates.
Japanese encephalitis virus (JEV), a prototypic virus of the mosquito-borne complex of Flavivirus, is widespread in east and south Asia, and ϳ 50,000 cases of infection by this virus are reported annually. 1 In Korea, JEV was first isolated from an American soldier in 1946. 2 The disease persisted thereafter at near-epidemic levels, with 1,000 cases annually until 1969. 3 Since the last epidemic in 1982, a largely expanded immunization program was carried out by the Korean government. After this mass vaccination, the number of JEV cases was dramatically reduced to 3-4 cases per year. There were no official JEV cases in Korea from 1994 to 1997; however, 3 cases were reported in 1998 and 1 case in 1999. 3 However, JEV in the wild has been isolated from mosquitoes in Korea every year. 3 Therefore, we need to check antigenic and genetic characterization of JEV isolated from Korea every year.
Previously, we reported the partial prM sequences of 4 Korean JEV isolates (K94P05, K92P55, K87P39, and K82P01). 4 When their sequences were compared with those of other JEV isolates, the 4 Korean JEV isolates belonged to one major genotype of Asian JEV. However, these Korean isolates formed a genetically distinct group in the phylogenetic tree by the envelope sequences of JEV. 5 There also seemed to be antigenic differences compared with other JEV isolates on the basis of a pH dependency pattern of hemagglutination. 4 To confirm the genetic and antigenic characterization of Korean JEV isolates in this study, the full-length genome sequence of a Korean JEV isolate, K94P05, was determined and compared with other JEV isolates. We also serologically characterized Korean JEV isolates by the cross-neutralization test.
We used 4 Korean JEV isolates (K94P05, K92P55, K87P39, and K82P01), Nakayama-NIH, JaGAr01, and Beijing-1. The history of the JEV isolates used and compared in this study is listed in Table 1 . The extraction of viral genomic RNA, reverse transcription, and polymerase chain reaction (PCR) amplification and sequencing methods were reported previously. [4] [5] [6] The PCR primers used in this study were designed on the basis of JaOArS982 sequences (Table  2) . Nucleotide assignments were confirmed by an independent PCR amplification. If there were differences between 2 sequence results, then a third independent PCR amplification was performed to determine nucleotide sequences. To determine the sequences at the ends of the 5Ј and 3Ј noncoding regions (NCR), the cap structure was removed from the purified virion K94P05 RNA genome with the tobacco acid pyrophosphatase (Epicentre Tech, Madison, WI). The 5Ј and 3Ј ends of the genome were ligated together by RNA ligase (Pharmacia Biotech, Piscataway, NJ). Circularized virus genomic RNA was then subjected to cDNA synthesis and PCR amplification of the region flanking the 5Ј and 3Ј termini. cDNA synthesis was accomplished with JEV-30R. For PCR amplification of the region covering the 5Ј and 3Ј termini, the next set of primers was used with JEV-29 and JEV-30R, and JEV-31 and JEV-32R for nested PCR amplification (Table 2). For the cross-neutralization test, polyclonal sera against JEV isolates were prepared from guinea pigs for each JEV isolate: K94P05, K87P39, and Nakayama-NIH. The sera were heat inactivated at 56ЊC for 30 min and were shown to have JEV antibodies by immunofluorescent staining. The neutralization test was modified from a previous report. 7 The complete sequence of K94P05 determined in the present study was deposited in GenBank (accession number AF045551). The genomic sequence of K94P05 consisted of 10,963 nucleotides that were 13 or 14 nucleotides shorter than those of other JEV isolates (Table 1) . However, the length of the deduced amino acid sequence of K94P05 was 3,432 residues, the same number as the other JEV isolates. Because Nakayama-NIH is the vaccine strain in Korea, we attempted to compare this strain and Korean isolates. Surprisingly, the full-length genome sequence of Nakayama-NIH has not yet been obtained. The envelope gene nucleotide sequence of Nakayama-NIH was similar to JaOArS982 and Beijing-1 (97.0% and 97.9% homology). However, the homology of the envelope gene nucleotide sequence between Nakayama-NIH and K94P05 was only 87.6%. 5 We † Partial 3Ј noncoding region sequences. ‡ Nakayama-NIH has only core, prM, envelope, NS1, and NS2 sequences. FIGURE 1. Phylogenetic tree showing the genetic relationship among Japanese encephalitis virus (JEV) isolates. This tree was constructed with the full-length genome sequences of 13 JEV isolates. Multiple sequence alignments obtained by CLUSTAL W (version 1.6) were manually edited. The tree was constructed with the aid of PAUPSEARCH and PAUPDISPLAY from the PAUP software package (version 4.0). Bootstrap 75% majority rule consensus trees (midpoint rooting) were obtained by performing heuristic search (optimality criterion, maximum parsimony; all characters equal weight; 100 replicates). Branch length is drawn in proportion to number of character changes along that branch. The tree was displayed by aid of TREEVIEW (version 1.5).
therefore compared K94P05 with other previously reported complete genome sequences of JEV isolates for analysis of genetic variation. Full-length nucleotide (amino acid) sequence comparisons showed 89.0-89.6% (96.4-97.3%) homology between K94P05 and other JEV isolates. The homology with other JEV isolates excluding K94P05 was 95.7-99.5% for the full-length nucleotide and 98.2-99.7% for the full-length amino acid sequence (Table 3 ). There was ϳ 10% difference in homology at the nucleotide level and ϳ 1-2% difference in homology at the amino acid level. These homology data showed K94P05 to be a distinct isolate compared with other Asian JEV isolates. Furthermore, the phylogenetic topology constructed from full-length genome nucleotide sequences showed that K94P05 belonged in a clearly different genetic group (Figure 1) . Taken together, these data suggest that the Korean JEV isolate may have spread to Korea from another Asian country many years ago and may have varied independently from other Asian JEV isolates.
A region of ϳ 60 nucleotides immediately downstream of the open reading frame stop codon of K94P05 showed high sequence variability as compared with other JEV isolates (Figure 2) . Deletions in the 3Ј NCR account for the size difference in the genomes between K94P05 and other JEV isolates (10,963 bp and 10,976 bp, or 10,977 bp, respectively). The 3Ј NCR of K94P05 comprises 572 bases, but JaGAr01 and Vellore P20778 have 586 bases, and the other JEV strains have 585 bases. Only K94P05 (Korea) and FU and NO (Badu Island, Torres Strait) isolates showed a polymorphic region just downstream of the stop codon in 3Ј NCR (Figure 2 ). Sequence heterogeneity of the 3Ј NCR of the genus Flavivirus was also observed in tick-borne encephalitis virus. 8 The end of 3Ј NCR of flavivirus has a conserved sequence and secondary structure, and therefore it may have a function in RNA synthesis and genome packaging during viral replication. 9 The function or effect of this variable region of 3Ј NCR of flavivirus, including tick-borne encephalitis virus and JEV, remains to be determined. However, recently, we found that this variable region in JEV 3Ј NCR may play a role in the rate of replication of viral RNA (Nam J and others, unpublished data). Currently, studies are under way to understand the significance of this region in the 3Ј NCR of JEV.
In hemagglutination test, the optimal pH of Korean strains (pH 6.6-7.0) was different compared with that of the Nakayama-NIH (pH 6.4), the vaccine strain in Korea. 4 Therefore, we made polyclonal antibodies to Nakayama-NIH, K87P39, and K94P05 for a cross-neutralization test. Korean JEV isolate-derived polyclonal antibodies showed 3 times higher neutralizing titer against Korean JEV isolates compared with Nakayama-NIH-derived polyclonal antibodies (Figure 3) . However, Nakayama-NIH-derived polyclonal antibodies can also protect against infection with Korean JEV isolates into BHK-21 cells. Therefore, it seemed reasonable that Nakayama-NIH strain should be used as vaccine in Korea. However, other analyses of strain variation by means of monoclonal antibodies and cross-neutralization assays have led to the suggestion that the inactivated Nakayama-NIH or Beijing-1 vaccine may not be effective in epidemic areas where antigenically different strains prevail. 7, [10] [11] [12] [13] [14] [15] Therefore, more detailed genetic and antigenic information on the Korean JEV isolates is needed.
In the present study, we determined the complete genomic sequence of the Korean JEV isolate K94P05 to be a 10,963-nucleotide-long RNA genome. Its sequence and other complete JEV sequences previously reported were aligned and analyzed. Approximately 60 nucleotides immediately downstream of the translation stop codon in the 3Ј NCR showed a polymorphic pattern. Therefore, this variable region in 3Ј NCR of JEV could be useful to assay the genetic relationship between various JEV isolates. On the basis of nucleotide and amino acid sequence homologies and phylogenetic data, K94P05 is genetically distinct compared with other JEV isolates, including Nakayama-NIH, the current vaccine strain used in Korea. It is important to further investigate the genetic and antigenic characteristics of the wild JEV isolates from Korea in order to determine the efficacy of the current vaccine strain in the Korean population. 
